Results of systematic second-look surgery plus hipec in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis

Annals of Surgery

Volumn 254, Issue 2, 2011, Pages 289-293

  Elias, D ^a   Honore C ^a   Dumont, F ^a   Ducreux, M ^a   Boige, V ^a   Malka, D ^a   Burtin, P ^a   Dromain, C ^a   Goere D ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GLUCOSE; IRINOTECAN; OXALIPLATIN;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLORECTAL ANASTOMOSIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LAPAROTOMY; LUNG INFECTION; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); OVARY METASTASIS; OVERALL SURVIVAL; POSTOPERATIVE HEMORRHAGE; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SECOND LOOK SURGERY; SURVIVAL RATE; THERAPY; TUMOR LOCALIZATION; TUMOR PERFORATION;

ADULT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOPLASM SEEDING; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; SECOND-LOOK SURGERY;

EID: 79961024562     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31822638f6     Document Type: Article

References (30)

1. Rosen SA, Buell JF, Yohida A, et al. Initial presentation with stage IV colorectal cancer. Arch Surg 2000;135:503-505.
2. Sugarbaker PH. Surgical management of carcinomatosis from colorectal cancer. Clin Colon Rectal Surg 2005;18:190-203. (Pubitemid 41262747)
3. Esquivel J, Elias D, Barrati D, et al. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008;98:263-267.
4. Sugarbaker PH. A perspective on clinical research strategies in carcinoma of the large bowel. World J Surg 1991;15:609-616.
5. Verwaal VC, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis from colorectal cancer. J Clin Oncol 2003;21:3737-3743. (Pubitemid 46606227)
6. Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010;28:63-68.
7. Sugarbaker PH, Schellinx ME, Chang D, et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585-592. (Pubitemid 26184134)
8. Verwaal VJ, van Ruth S, Witkamp A, et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005;12:65-71. (Pubitemid 40486643)
9. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin. Long term results of intraperitoneal chemohyperthermia with oxaliplatin following complete cytoreductive surgery. Gastroenterol Clin Biol 2006;30:1200-1204. (Pubitemid 44682573)
10. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with intraperitoneal chemotherapy for management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2003;22:3284-3292.
11. Elias D, Goere D, Di Pietrantonio D, et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2007;247:445-450.
12. Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996;82:359-374.
13. Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 1991;34:723-727.
14. Elias D, El Otmany A, Bonnay M, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncol 2002;63:346-352. (Pubitemid 36151527)
15. Elias D, Matsuhisa T, Sideris L, et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 2004 15:1558-1565. (Pubitemid 39409748)
16. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213. (Pubitemid 38963009)
17. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-196.
18. Wangensteen OH. Cancer of the colon and rectum; with special reference to earlier recognition of alimentary tract malignancy; secondary delayed re-entry of the abdomen in patients exhibiting lymph node involvement; subtotal primary excision of the colon; operation in obstruction. Wis Med J. 1949;48:591-597.
19. Gilbersten VA, Wangensteen OH. A summary of thirteen years' experience with the second look program. Surg Gynecol Obstet 1962;114:438-442.
20. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985;55:1284-1290. (Pubitemid 15143405)
21. Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006 243:212-222. (Pubitemid 43185440)
22. Lefevre JH, Elias DM. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence. Cancer J 2009;15:200-203.
23. Willett C, Tepper JE, Cohen A, et al. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985;3:379-384. (Pubitemid 15132006)
24. Yang SH, Lin JK, Lai CR, et al. Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol 2004;87:167-173.
25. Cheynel N, Cortet M, Lepage C, et al. Incidence, patterns of failure, and prognosis of perforated colorectal cancers in a well-defined population. Dis Colon Rectum 2009;52:406-411.
26. Ogawa M, Watanabe M, Eto K, et al. Clinicopathological features of perforated colorectal cancer. Anticancer Res 2009;29:1681-1684.
27. Chung TS, Chang HJ, Jung KH, et al. Role of surgery in the treatment of ovarian metastases from colorectal cancer. J Surg Oncol 2009;100:570-574.
28. Tan KL, Tan WS, Lim JF, et al. Krukenberg tumors of colorectal origin: a dismal outcome-experience of a tertiary center. Int J Colorectal Dis 2010;25:233-238.
29. Gunderson LL, Sosin H, Levitt S. Extrapelvic colon-areas of failure in a reoperation series: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1985;11:731-741. (Pubitemid 15086896)
30. Sugarbaker PH, Gianola FJ, Speyer JC, et al. Prospective randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surg 1985;98:414-422. (Pubitemid 16143766)